<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
     xmlns:admin="http://webns.net/mvcb/"
     xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
     xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>My American Doctor &#45; admin</title>
<link>https://myamericandoctor.in/rss/author/admin</link>
<description>My American Doctor &#45; admin</description>
<dc:language>en</dc:language>
<dc:rights>@myamericandoctor.in</dc:rights>

<item>
<title>The PSA Dilemma: What Your Doctor May Not Be Telling You About Prostate Cancer Screening</title>
<link>https://myamericandoctor.in/psa-prostate-cancer-screening-controversy</link>
<guid>https://myamericandoctor.in/psa-prostate-cancer-screening-controversy</guid>
<description><![CDATA[ Prostate cancer is the second most common cancer in men globally, yet its primary screening tool — the PSA blood test — remains deeply controversial. While PSA testing can detect cancer early and reduce mortality, it is not cancer-specific, frequently producing false positives that trigger unnecessary biopsies and overtreatment. Major medical bodies disagree on screening guidelines, but universally recommend shared decision-making between patient and doctor. Higher-risk men — those with family history, of African descent, or carrying BRCA2 mutations — should consider earlier screening. Emerging technologies like MRI-guided biopsies and advanced biomarkers are improving precision and gradually shifting the benefit-harm balance toward screening. ]]></description>
<enclosure url="https://myamericandoctor.in/uploads/images/202602/image_870x580_699521fb62b29.jpg" length="132802" type="image/jpeg"/>
<pubDate>Wed, 18 Feb 2026 07:51:01 +0530</pubDate>
<dc:creator>admin</dc:creator>
<media:keywords>Primary: prostate cancer screening India, PSA test controversy, prostate cancer PSA test, prostate cancer screening guidelines, when to get PSA test, prostate cancer early detection Secondary: PSA false positive, overdiagnosis prostate cancer, active surveillance prostate cancer, prostate cancer screening age, BRCA2 prostate cancer risk, MRI guided prostate biopsy Long-tail: should I get a PSA test at 50, is PSA test reliable for prostate cancer, prostate cancer screening shared decision making</media:keywords>
</item>

</channel>
</rss>